ProCE Banner Activity

Frequently Asked Questions on COVID-19 Treatments

Text Module

In this module, expert faculty answer clinician questions about COVID-19 treatment options. New questions will be added and responses will be further developed often as more data emerge.

Released: July 08, 2020

Expiration: July 07, 2021

Share

Faculty

Arthur Kim

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease
The University of Melbourne
Consultant Physician
Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Jens D. Lundgren

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Vikramjit Mukherjee

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Roger Paredes

Roger Paredes, MD, PhD

Head, Microbial Genomics  
irsiCaixa AIDS Research Institute
Head
Department of Infectious Diseases
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, Spain

Lynora Saxinger

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Leo Yee-Sin

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS

Professor
Lee Kong Chian School of Medicine
Saw Swee Hock School of Public Health
Nanyang Technological University
National University of Singapore
Senior Consultant
National Centre for Infectious Disease
Singapore

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD, has no relevant conflicts of interest to report.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease
The University of Melbourne
Consultant Physician
Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant conflicts of interest to report.

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Vikramjit Mukherjee, MD, has no relevant conflicts of interest to report.

Roger Paredes, MD, PhD

Head, Microbial Genomics  
irsiCaixa AIDS Research Institute
Head
Department of Infectious Diseases
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, Spain

Roger Paredes, MD, PhD, has disclosed that he has received funds for research support from MSD and ViiV and consulting fees from Gilead Sciences, MDS, and ViiV.

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Lynora Saxinger, MD, FRCPC, CTropMed, has no relevant conflicts of interest to report.

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS

Professor
Lee Kong Chian School of Medicine
Saw Swee Hock School of Public Health
Nanyang Technological University
National University of Singapore
Senior Consultant
National Centre for Infectious Disease
Singapore

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS, has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant conflicts of interest to report.